工業富聯(601138.SH)新增醫用口罩生產:優先用於內部生產防疫保障 月底或實現日產200萬隻口罩
格隆匯2月7日丨工業富聯(601138.SH)公佈,在2020年2月6日晚富士康微信公眾號發佈《戰“疫”,富士康在行動》一文中,包含了公司生產口罩事宜,現對相關事項説明如下:
1、公司主營業務未發生變化,新增從事醫用口罩的生產,是在新型冠狀病毒肺炎防治的大背景下,基於落實當地政府要求,迅速應對疫情所需;目前預計2月底可實現日產200萬隻的產能計劃,優先用於富士康科技集團近百萬員工內部生產防疫保障;不佔用社會資源,為民眾口罩需求騰出空間;未來視情況積極對外支援輸出,為當前疫情防控工作提供有力支撐;
2、且鑑於使用安排和用途,預計對公司經營業績影響較小。
3、在各級政府的支持與關心下,目前首條日產10萬隻口罩生產線尚處於試產階段,產品資質認證尚在申請中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.